IDEX Health & Science, LLC announced the release of a novel instrument to measure protein titer directly from a bioreactor in real time.
Rohnert Park, CA, July 15th 2019 — IDEX Health & Science, LLC (IH&S) today announced the release of a novel instrument to measure protein titer directly from a bioreactor in real time. Tridex™ Protein Analyzer is a complete solution for at-line titer monitoring in a bioprocess environment that is compact and easy-to-use. It is built for bioprocess to ensure at-line results directly correlate to offline HPLC methodology.
The measurement of antibody titer is a critical parameter for manufacturing biologics and biosimilars. The biopharma industry has long been seeking an alternative to time-consuming offline methods currently in use. The Tridex Analyzer quickly delivers accurate titer measurements over a dynamic range of 0.1 – 10 g/L, with minimal sample manipulation for use in R&D and process development.
The Tridex Analyzer is the first protein analyzer on the market built specifically for bioprocess monitoring. It uses a unique trap and elute technique to accurately monitor the titer in a bioreactor. It does not require chromatography expertise, specialized training or extensive method development. The sample flowpath is completely enclosed, lending itself to the requirements of single use.
The option to connect to an automated sampling system allows the Tridex system to integrate completely into a bioprocessing environment and deliver actionable results with just a few clicks.
Kurt Pickle, Business Line Leader for Bioprocess Analytics, commented: The Tridex Protein Analyzer unlocks true process insights with the shortest time from sample to result at just under 5 minutes. We are confident that Tridex will fill a gap in this market, delivering speed, accuracy and ease-of-use and ultimately improving efficiencies in the drug development process.”
For more information about the Tridex workflow, and how results compare to HPLC methodology, visit: https://www.idex-hs.com/
